ACM
PTCT icon

Asymmetry Capital Management’s PTC Therapeutics PTCT Stock Holding History

Asymmetry Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-215,985
Closed -$8.04M – 35
2021
Q3 		$8.04M Buy
+215,985
New +$8.87M 4.83% 10
2020
Q3 		– Sell
-73,708
Closed -$3.74M – 43
2020
Q2 		$3.74M Sell
73,708
-26,762
-27% -$1.31M 2.87% 15
2020
Q1 		$4.48M Buy
100,470
+45,062
+81% +$2.27M 4.9% 6
2019
Q4 		$2.66M Sell
55,408
-65,041
-54% -$2.76M 4.77% 7
2019
Q3 		$4.07M Sell
120,449
-160,093
-57% -$6.97M 8.73% 2
2019
Q2 		$12.6M Buy
280,542
+127,714
+84% +$5.04M 6.84% 6
2019
Q1 		$5.75M Buy
152,828
+42,034
+38% +$1.41M 9.61% 2
2018
Q4 		$3.8M Sell
110,794
-62,216
-36% -$2.24M 10.5% 3
2018
Q3 		$8.13M Sell
173,010
-32,021
-16% -$1.32M 7.51% 1
2018
Q2 		$6.92M Sell
205,031
-114,413
-36% -$3.57M 6.8% 3
2018
Q1 		$8.64M Sell
319,444
-232,114
-42% -$5.88M 10.81% 1
2017
Q4 		$9.2M Buy
551,558
+196,102
+55% +$3.32M 12.49% 1
2017
Q3 		$7.11M Sell
355,456
-172,659
-33% -$3.38M 8.25% 1
2017
Q2 		$9.68M Sell
528,115
-92,219
-15% -$1.24M 11.48% 1
2017
Q1 		$6.1M Buy
620,334
+135,755
+28% +$1.64M 8.51% 1
2016
Q4 		$5.29M Sell
484,579
-83,104
-15% -$872K 9.83% 1
2016
Q3 		$7.95M Buy
567,683
+261,033
+85% +$2.12M 13.83% 1
2016
Q2 		$2.15M Buy
+306,650
New +$2.25M 3.94% 11
2016
Q1 		– Sell
-237,100
Closed -$7.68M – 19
2015
Q4 		$7.68M Buy
+237,100
New +$6.98M 11.62% 1

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Asymmetry Capital Management's PTCT Position: Q4 2021 in Review

Asymmetry Capital Management sold out of PTC Therapeutics (PTCT) in Q4 2021, closing a stake of 215,985 shares — an estimated $8.04M sold.

Asymmetry Capital Management first reported a position in PTCT in Q4 2015 and held it in 19 quarters. The position peaked at $12.6M in Q2 2019. 178 funds tracked by Wall St. Rank hold PTCT as of Q4 2021.

  • Asymmetry Capital Management reported no remaining PTC Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 215,985 PTC Therapeutics shares in Q4 2021, an estimated $8.04M.
  • Asymmetry Capital Management first reported a position in PTC Therapeutics in Q4 2015 and held it in 19 quarters.
  • Asymmetry Capital Management's PTC Therapeutics position peaked at $12.6M in Q2 2019.
  • 178 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.